Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Operating expenses:
Research and development expense	$ 103,731	$ 79,347
General and administrative expense	25,956	28,793
Total operating expenses	129,687	108,140
Loss from operations	(129,687)	(108,140)
Other income (expense):
Interest income	6,312	1,648
Other income (expense)	(87)	10
Total other income (expense)	6,225	1,658
Consolidated net loss and comprehensive loss	$ (123,462)	$ (106,482)
Net loss per common share, basic	$ (2.58)	$ (2.74)
Net loss per common share, diluted	$ (2.58)	$ (2.74)
Weighted-average shares of common stock outstanding, basic	47,777,568	38,927,268
Weighted-average shares of common stock outstanding, diluted	47,777,568	38,927,268